These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7937321)

  • 1. Peptidic endothelin-1 receptor antagonist, BQ-123, and neuroprotection.
    Feuerstein G; Gu JL; Ohlstein EH; Barone FC; Yue TL
    Peptides; 1994; 15(3):467-9. PubMed ID: 7937321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection.
    Clozel M; Watanabe H
    Life Sci; 1993; 52(9):825-34. PubMed ID: 8437512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y; Oliver JR; Horowitz JD
    Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
    Warner TD; Allcock GH; Vane JR
    Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glycine antagonist and free radical scavenger 7-Cl-thio-kynurenate reduces CA1 ischemic damage in the gerbil.
    Pellegrini-Giampietro DE; Cozzi A; Moroni F
    Neuroscience; 1994 Dec; 63(3):701-9. PubMed ID: 7898671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor.
    Ihara M; Ishikawa K; Fukuroda T; Saeki T; Funabashi K; Fukami T; Suda H; Yano M
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S11-4. PubMed ID: 1282942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
    Warner TD; Allcock GH; Corder R; Vane JR
    Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats.
    Mino N; Kobayashi M; Nakajima A; Amano H; Shimamoto K; Ishikawa K; Watanabe K; Nishikibe M; Yano M; Ikemoto F
    Eur J Pharmacol; 1992 Oct; 221(1):77-83. PubMed ID: 1459192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.
    Hay DW; Luttmann MA; Beck G; Ohlstein EH
    Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.
    Allcock GH; Warner TD; Vane JR
    Br J Pharmacol; 1995 Nov; 116(5):2482-6. PubMed ID: 8581288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous endothelin-1 impairs endothelium-dependent relaxation after myocardial ischemia and reperfusion.
    Hagar JM
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1833-41. PubMed ID: 7977813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
    Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
    Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BQ-123 inhibits both endothelin 1 and endothelin 3 mediated C6 rat glioma cell proliferation suggesting an atypical endothelin receptor.
    Sedo ; Provero P; Revoltella RP; Di Bartolo V; Beffy P; Mizrahi J
    J Biol Regul Homeost Agents; 1993; 7(3):95-8. PubMed ID: 8135146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral postischemic hypoperfusion is mediated by ETA receptors.
    Spatz M; Yasuma Y; Strasser A; McCarron RM
    Brain Res; 1996 Jul; 726(1-2):242-6. PubMed ID: 8836568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of BQ-123, an ETA recepter-selective antagonist, on changes of intraocular pressure, blood-aqueous barrier and aqueous prostaglandin concentrations caused by endothelin-1 in rabbit.
    Haque MS; Sugiyama K; Taniguchi T; Kitazawa Y
    Jpn J Ophthalmol; 1996; 40(1):26-32. PubMed ID: 8739497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketanserin reduces neuronal calcium accumulation and cell death in the hippocampus of the Mongolian gerbil after transient forebrain ischemia.
    Klisch J; Bode-Greuel KM
    Brain Res; 1992 Apr; 578(1-2):1-7. PubMed ID: 1511266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin antagonists diminish postischemic microvascular incompetence and necrosis in the heart.
    Maxwell L; Harrison WR; Gavin JB
    Microvasc Res; 2000 Mar; 59(2):204-12. PubMed ID: 10684726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new endothelin receptor antagonist, TAK-044, shows long-lasting inhibition of both ETA- and ETB-mediated blood pressure responses in rats.
    Ikeda S; Awane Y; Kusumoto K; Wakimasu M; Watanabe T; Fujino M
    J Pharmacol Exp Ther; 1994 Aug; 270(2):728-33. PubMed ID: 8071866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperresponsiveness to ET-1 after treatment with a mixture of ETA and ETB receptor antagonists in the rabbit in vivo and in vitro.
    D'Orléans-Juste P; Yano M; Maurice MC; Gratton JP
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S369-72. PubMed ID: 8587417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endothelin in mediating ischemia/hypoxia-induced atrial natriuretic peptide release.
    Zhang Y; Oliver JR; Horowitz JD
    J Cardiovasc Pharmacol; 2004 Feb; 43(2):227-33. PubMed ID: 14716210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.